Avadel Pharmaceuticals Sets New 52-Week High at 17.43 - Defense World
AVDL Stock | USD 9.13 0.25 2.82% |
About 55% of Avadel Pharmaceuticals' institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Avadel Pharmaceuticals PLC stock suggests that some investors are interested at this time. Avadel Pharmaceuticals' investing sentiment shows overall attitude of investors towards Avadel Pharmaceuticals PLC.
Avadel Pharmaceuticals Sets New 52-Week High at 17.43 Defense World
Read at news.google.com
![]() |
Avadel Pharmaceuticals Fundamental Analysis
We analyze Avadel Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avadel Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avadel Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Avadel Pharmaceuticals is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Avadel Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avadel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Avadel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Avadel Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Avadel Pharmaceuticals Related Equities
DERM | Journey Medical | 2.64 | ||||
AQST | Aquestive Therapeutics | 2.62 | ||||
EVOK | Evoke Pharma | 1.62 | ||||
ANIP | ANI Pharmaceuticals | 0.91 | ||||
NBIX | Neurocrine Biosciences | 0.89 | ||||
LFCR | Lifecore Biomedical | 0.75 | ||||
DVAX | Dynavax Technologies | 0.20 | ||||
AMRX | Amneal Pharmaceuticals, | 0.42 | ||||
ASRT | Assertio Therapeutics | 1.41 | ||||
ALKS | Alkermes Plc | 2.33 | ||||
IRWD | Ironwood Pharmaceuticals | 8.06 |
Check out Avadel Pharmaceuticals Hype Analysis, Avadel Pharmaceuticals Correlation and Avadel Pharmaceuticals Performance. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.